These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 11305380)

  • 61. Folate supplementation reduces the side effects of methotrexate therapy for psoriasis.
    Baran W; Batycka-Baran A; Zychowska M; Bieniek A; Szepietowski JC
    Expert Opin Drug Saf; 2014 Aug; 13(8):1015-21. PubMed ID: 24972718
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Methotrexate: safe if prescribed correctly].
    Verduijn MM; van den Bemt BJ; Dijkmans BA; van der Waal RI; Horikx A
    Ned Tijdschr Geneeskd; 2009; 153():A695. PubMed ID: 19785857
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis.
    Chládek J; Simková M; Vanecková J; Hroch M; Chládkova J; Martínková J; Vávrová J; Beránek M
    Eur J Clin Pharmacol; 2008 Apr; 64(4):347-55. PubMed ID: 18163165
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Methotrexate versus hydroxycarbamide (hydroxyurea) as a weekly dose to treat moderate-to-severe chronic plaque psoriasis: a comparative study.
    Ranjan N; Sharma NL; Shanker V; Mahajan VK; Tegta GR
    J Dermatolog Treat; 2007; 18(5):295-300. PubMed ID: 17852635
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
    Carneiro SC; Cássia FF; Lamy F; Chagas VL; Ramos-e-Silva M
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):25-9. PubMed ID: 18181969
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines.
    Busger Op Vollenbroek FTM; Doggen CJM; Janssens RWA; Bernelot Moens HJ
    PLoS One; 2018; 13(3):e0194401. PubMed ID: 29570708
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Australasian Psoriasis Collaboration view on methotrexate for psoriasis in the Australasian setting.
    Rademaker M; Gupta M; Andrews M; Armour K; Baker C; Foley P; Gebauer K; George J; Rubel D; Sullivan J
    Australas J Dermatol; 2017 Aug; 58(3):166-170. PubMed ID: 27402434
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparative tolerability of systemic treatments for plaque-type psoriasis.
    McClure SL; Valentine J; Gordon KB
    Drug Saf; 2002; 25(13):913-27. PubMed ID: 12381213
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Methotrexate and ciclosporin combination for the treatment of severe psoriasis.
    Aydin F; Canturk T; Senturk N; Turanli AY
    Clin Exp Dermatol; 2006 Jul; 31(4):520-4. PubMed ID: 16716153
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials.
    West J; Ogston S; Foerster J
    PLoS One; 2016; 11(5):e0153740. PubMed ID: 27168193
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Methotrexate: long-term safety and efficacy in an Australian consultant rheumatology practice.
    Varatharajan N; Lim IG; Anandacoomarasamy A; Russo R; Byth K; Spencer DG; Manolios N; Howe GB
    Intern Med J; 2009 Apr; 39(4):228-36. PubMed ID: 19402861
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity.
    Montaudié H; Sbidian E; Paul C; Maza A; Gallini A; Aractingi S; Aubin F; Bachelez H; Cribier B; Joly P; Jullien D; Le Maître M; Misery L; Richard MA; Ortonne JP
    J Eur Acad Dermatol Venereol; 2011 May; 25 Suppl 2():12-8. PubMed ID: 21388454
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent.
    Berends MA; Snoek J; de Jong EM; van de Kerkhof PC; van Oijen MG; van Krieken JH; Drenth JP
    Aliment Pharmacol Ther; 2006 Sep; 24(5):805-11. PubMed ID: 16918884
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Determinants for drug survival of methotrexate in patients with psoriasis, split according to different reasons for discontinuation: results of the prospective MTX-CAPTURE.
    Otero ME; van den Reek JM; Seyger MM; van de Kerkhof PC; Kievit W; de Jong EM
    Br J Dermatol; 2017 Aug; 177(2):497-504. PubMed ID: 28078672
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Systemic Methotrexate Treatment in 42 Children with Severe Plaque Psoriasis: A Retrospective Study in China.
    Wang Z; Chen Y; Xiang X; Gu Y; Zhao M; Liu Y; Wang Y; Xu Z
    Dermatology; 2022; 238(5):919-927. PubMed ID: 35176737
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The use of low dose methotrexate in children with chronic anterior and intermediate uveitis.
    Malik AR; Pavesio C
    Br J Ophthalmol; 2005 Jul; 89(7):806-8. PubMed ID: 15965154
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Methotrexate for the treatment of adult atopic dermatitis.
    Goujon C; Bérard F; Dahel K; Guillot I; Hennino A; Nosbaum A; Saad N; Nicolas JF
    Eur J Dermatol; 2006; 16(2):155-8. PubMed ID: 16581567
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Treatment of psoriasis by methotrexate in the era of biotherapies: a study in 21 Tunisian patients].
    Khaled A; Ben Hamida M; Zeglaoui F; Kharfi M; Ezzine N; Fazaa B
    Therapie; 2012; 67(1):49-52. PubMed ID: 22487502
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Correct use of methotrexate].
    Verduijn MM; van den Bemt BJ; Dijkmans BA; van der Waal RI; Horikx A
    Ned Tijdschr Geneeskd; 2009; 153():A696. PubMed ID: 19785852
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
    Devine SM; Geller RB; Lin LB; Dix SP; Holland HK; Maurer D; O'Toole K; Keller J; Connaghan DG; Heffner LT; Hillyer CD; Rodey GE; Winton EF; Maher RM; Fitzsimmons WE; Wingard JR
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):25-33. PubMed ID: 9209738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.